These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7914056)

  • 1. Neuroleptics and the neuroleptic-induced deficit syndrome.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():8-13. PubMed ID: 7914056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():64-7. PubMed ID: 7914053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic dysphoria.
    Emerich DF; Sanberg PR
    Biol Psychiatry; 1991 Feb; 29(3):201-3. PubMed ID: 1673062
    [No Abstract]   [Full Text] [Related]  

  • 5. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic patients who become worse on neuroleptics.
    Bowers MB; Swigar ME
    J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-related dyskinesias in children and adolescents.
    Connor DF; Fletcher KE; Wood JS
    J Clin Psychiatry; 2001 Dec; 62(12):967-74. PubMed ID: 11780878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial dyskinesia: a 16-year follow-up study.
    McClelland HA; Metcalfe AV; Kerr TA; Dutta D; Watson P
    Br J Psychiatry; 1991 May; 158():691-6. PubMed ID: 1677601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic discontinuation syndromes.
    Tranter R; Healy D
    J Psychopharmacol; 1998; 12(4):401-6. PubMed ID: 10065916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic induced deficit syndrome].
    Szafrański T
    Psychiatr Pol; 1995; 29(3):359-69. PubMed ID: 7652089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective response to neuroleptics in schizophrenia.
    Awad AG
    Schizophr Bull; 1993; 19(3):609-18. PubMed ID: 7901897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic associated tardive dyskinesias in young people with psychoses.
    Pourcher E; Baruch P; Bouchard RH; Filteau MJ; Bergeron D
    Br J Psychiatry; 1995 Jun; 166(6):768-72. PubMed ID: 7663825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenomenology and therapy of neuroleptic-induced akathisia--a review of the literature].
    Seidel M
    Fortschr Neurol Psychiatr; 1989 Nov; 57(11):489-94. PubMed ID: 2574702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in older out-patients: a follow-up study.
    Labbate LA; Lande RG; Jones F; Oleshansky MA
    Acta Psychiatr Scand; 1997 Sep; 96(3):195-8. PubMed ID: 9296550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
    Bollini P; Pampallona S; Orza MJ; Adams ME; Chalmers TC
    Psychol Med; 1994 May; 24(2):307-16. PubMed ID: 7916157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of neuroleptic-induced extrapyramidal side effects by Kava special extract WS 1490.
    Boerner RJ; Klement S
    Wien Med Wochenschr; 2004 Nov; 154(21-22):508-10. PubMed ID: 15638068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.